On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...